Simcere Pharmaceutical Group Limited (2096.HK)

HKD 8.99

(2.63%)

Long Term Debt Summary of Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited's latest annual long term debt in 2023 was 334.24 Million CNY , up 114.37% from previous year.
Simcere Pharmaceutical Group Limited's latest quarterly long term debt in 2024 Q1 was 8.51 Million CNY , down -95.86% from previous quarter.
Simcere Pharmaceutical Group Limited reported annual long term debt of 155.92 Million CNY in 2022, up 110.03% from previous year.
Simcere Pharmaceutical Group Limited reported annual long term debt of 74.23 Million CNY in 2021, down -94.95% from previous year.
Simcere Pharmaceutical Group Limited reported quarterly long term debt of 8.51 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Simcere Pharmaceutical Group Limited reported quarterly long term debt of 334.24 Million CNY for 2023 Q3, down -45.98% from previous quarter.

Annual Long Term Debt Chart of Simcere Pharmaceutical Group Limited (2023 - 2012)

Historical Annual Long Term Debt of Simcere Pharmaceutical Group Limited (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	334.24 Million CNY	114.37%
2022	155.92 Million CNY	110.03%
2021	74.23 Million CNY	-94.95%
2020	1.46 Billion CNY	15.6%
2019	1.27 Billion CNY	950.15%
2018	121 Million CNY	-60.09%
2017	303.21 Million CNY	0.0%
2012	2 Million CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	8.51 Million CNY	-95.86%
2024 Q2	8.51 Million CNY	0.0%
2023 Q3	334.24 Million CNY	-45.98%
2023 Q4	334.24 Million CNY	0.0%
2023 FY	334.24 Million CNY	114.37%
2023 Q1	618.72 Million CNY	296.82%
2023 Q2	618.72 Million CNY	0.0%
2022 FY	155.92 Million CNY	110.03%
2022 Q4	155.92 Million CNY	0.0%
2022 Q3	155.92 Million CNY	-8.42%
2022 Q2	170.25 Million CNY	0.0%
2022 Q1	170.25 Million CNY	129.33%
2021 Q3	74.23 Million CNY	-40.09%
2021 Q2	123.92 Million CNY	0.0%
2021 Q1	123.92 Million CNY	-91.56%
2021 FY	74.23 Million CNY	-94.95%
2021 Q4	74.23 Million CNY	0.0%
2020 Q4	1.46 Billion CNY	0.0%
2020 Q2	1.42 Billion CNY	0.0%
2020 Q1	1.42 Billion CNY	11.8%
2020 FY	1.46 Billion CNY	15.6%
2020 Q3	1.46 Billion CNY	3.39%
2019 Q4	1.27 Billion CNY	0.0%
2019 Q1	- CNY	0.0%
2019 FY	1.27 Billion CNY	950.15%
2019 Q3	1.27 Billion CNY	0.0%
2018 FY	121 Million CNY	-60.09%
2017 FY	303.21 Million CNY	0.0%
2013 Q1	2 Million CNY	0.0%
2013 Q3	186.44 Million CNY	9222.0%
2013 Q2	2 Million CNY	0.0%
2012 Q4	2 Million CNY	0.0%
2012 FY	2 Million CNY	0.0%
2012 Q1	2.46 Million CNY	0.0%
2012 Q2	2.44 Million CNY	-0.96%
2012 Q3	2 Million CNY	-18.05%

Peer Long Term Debt Comparison of Simcere Pharmaceutical Group Limited

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-991.869%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	92.178%